Diltiazem

What is Diltiazem?

Diltiazem is a pharmaceutical compound classified as a non-dihydropyridine calcium channel blocker. It is widely utilized in cardiology for its ability to dilate blood vessels and reduce the heart's workload. Primarily prescribed for the management of hypertension (high blood pressure), angina pectoris (chest pain due to reduced blood flow to the heart), and certain cardiac arrhythmias (irregular heartbeats), Diltiazem works by affecting the movement of calcium into the cells of the heart and blood vessels. This action leads to a relaxation of vascular smooth muscle, resulting in vasodilation and improved blood flow.

The history of calcium channel blockers dates back to the 1960s, with Diltiazem emerging as a significant therapeutic option. It was developed to offer a balanced profile of both vascular and cardiac effects, distinguishing it from other calcium channel blockers that might predominantly affect either the vasculature or the heart. Its introduction provided clinicians with a versatile tool for treating a range of cardiovascular conditions, improving patient outcomes by effectively controlling symptoms and reducing cardiovascular risk.

As a member of the benzothiazepine class of calcium channel blockers, Diltiazem is identified by the Anatomical Therapeutic Chemical (ATC) code C08, which specifically designates calcium channel blockers. It is available in various formulations, including immediate-release tablets, extended-release capsules, and intravenous injections, allowing for flexible dosing regimens tailored to individual patient needs and the specific condition being treated. The extended-release forms are particularly beneficial for once-daily dosing, enhancing patient adherence and providing consistent therapeutic effects throughout the day.

⚙️ Mechanism of Action

Diltiazem exerts its therapeutic effects by inhibiting the influx of extracellular calcium ions across the membranes of myocardial (heart muscle) and vascular smooth muscle cells. It achieves this by binding to and blocking the L-type voltage-gated calcium channels. These channels are crucial for the initiation and propagation of cardiac muscle contraction and vascular smooth muscle tone. By preventing calcium entry, Diltiazem reduces the availability of intracellular calcium, which is essential for the contractile process. This leads to a decrease in myocardial contractility, a reduction in the heart rate by slowing conduction through the sinoatrial (SA) and atrioventricular (AV) nodes, and relaxation of arterial smooth muscle.

The preferential effect of Diltiazem on both cardiac and vascular tissues sets it apart. In the heart, its action on the SA and AV nodes is particularly beneficial for controlling supraventricular tachyarrhythmias, as it prolongs the refractory period and slows conduction velocity. In the periphery, the relaxation of arterial smooth muscle results in systemic vasodilation, which decreases peripheral vascular resistance. This reduction in resistance directly lowers blood pressure and, by reducing afterload, decreases the oxygen demand of the heart. These combined actions make Diltiazem highly effective in managing angina by improving myocardial oxygen supply-demand balance and controlling hypertension.

• Blocks L-type voltage-gated calcium channels in cardiac and vascular smooth muscle.
• Decreases intracellular calcium availability, reducing muscle contraction.
• Slows conduction through the SA and AV nodes, reducing heart rate.
• Relaxes arterial smooth muscle, leading to vasodilation and decreased peripheral resistance.
• Reduces myocardial contractility and oxygen demand, improving angina symptoms.

🏥️ Medical Uses & Indications

Diltiazem is a versatile cardiovascular medication with a broad spectrum of clinical applications. Its unique pharmacological profile, balancing both cardiac and vascular effects, makes it an indispensable tool for managing several chronic and acute cardiovascular conditions. The choice of Diltiazem, its specific formulation, and dosage is always determined by a healthcare professional based on the patient's individual condition, medical history, and response to therapy.

Primary Indications

• Angina Pectoris: Used for the symptomatic treatment of chronic stable angina (exertional angina), vasospastic angina (Prinzmetal's angina), and unstable angina. It reduces the frequency and severity of anginal attacks by improving myocardial oxygen supply and reducing demand.
• Hypertension (High Blood Pressure): Effective as a monotherapy or in combination with other antihypertensive agents for the management of essential hypertension, lowering blood pressure by dilating peripheral arteries.
• Supraventricular Tachyarrhythmias: Employed to control the ventricular rate in patients with chronic atrial fibrillation or atrial flutter, and to terminate paroxysmal supraventricular tachycardia (PSVT) in acute settings (often intravenously).
• Post-Myocardial Infarction: Sometimes used to improve outcomes in certain patients post-MI, particularly those with non-Q-wave MIs, by reducing reinfarction and post-infarction angina.
• Hypertrophic Cardiomyopathy: Can be used to improve diastolic filling and reduce left ventricular outflow tract obstruction in some patients with hypertrophic obstructive cardiomyopathy.

Secondary / Off-label Uses

• Raynaud's Phenomenon: May be used to reduce the frequency and severity of vasospastic attacks in patients suffering from Raynaud's phenomenon, due to its vasodilatory properties.
• Migraine Prophylaxis: In some cases, Diltiazem has been explored as a prophylactic treatment for migraines, although it is not a first-line agent for this indication.
• Esophageal Spasms: The smooth muscle relaxant properties of Diltiazem can be beneficial in managing certain motility disorders of the esophagus, such as diffuse esophageal spasm.
• Pulmonary Hypertension: Occasionally used in the management of pulmonary hypertension, particularly in patients who demonstrate a vasodilator response to acute testing.

💊 Dosage & Administration

The dosage and administration of Diltiazem are highly individualized and depend on the specific indication, the patient's age, renal and hepatic function, and response to treatment. Diltiazem is available in several formulations, including immediate-release (IR) tablets, sustained-release (SR) capsules, and extended-release (ER) capsules, which allow for varying dosing frequencies. It is crucial to start with a low dose and titrate upwards gradually to achieve the desired therapeutic effect while minimizing side effects. Intravenous Diltiazem is reserved for acute situations, such as rapid ventricular rate control in atrial fibrillation or flutter, or for the rapid conversion of PSVT.

Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition.

⚠️ Side Effects

Like all medications, Diltiazem can cause side effects, although not everyone experiences them. Most side effects are mild to moderate and often resolve as the body adjusts to the medication. It is important to discuss any concerns with a healthcare provider.

Common Side Effects (>10%)

• Headache: Often mild and transient, usually at the beginning of therapy.
• Dizziness: Can occur due to blood pressure lowering effects, especially upon standing.
• Edema (swelling): Typically peripheral edema, affecting the ankles and feet.
• Bradycardia: A slower-than-normal heart rate.
• Flushing: A sensation of warmth and redness, particularly in the face and neck.
• Nausea: Mild gastrointestinal upset.

Less Common (1-10%)

• Fatigue or weakness.
• Constipation: A common gastrointestinal side effect.
• Rash: Various skin reactions, including pruritus (itching).
• Hypotension: Blood pressure that is too low, potentially causing lightheadedness or fainting.
• Gingival hyperplasia: Overgrowth of gum tissue, typically with long-term use.

Rare but Serious

• Severe Bradycardia or Heart Block: Diltiazem can significantly slow heart rate and impair cardiac conduction, potentially leading to symptomatic bradycardia or advanced AV block, especially in patients with pre-existing conduction abnormalities. This may require medical intervention, including pacemaker insertion in severe cases.
• Liver Dysfunction: Although rare, cases of elevated liver enzymes and hepatitis have been reported with Diltiazem use. Symptoms may include yellowing of the skin or eyes (jaundice), dark urine, or persistent nausea and vomiting.
• Stevens-Johnson Syndrome (SJS): An extremely rare but life-threatening severe cutaneous adverse reaction characterized by widespread blistering and epidermal detachment. Immediate medical attention is required if skin rash, blistering, or mucosal lesions develop.

🔄 Drug Interactions

Diltiazem is metabolized primarily by the cytochrome P450 3A4 (CYP3A4) enzyme system in the liver. This metabolic pathway means that Diltiazem can interact with numerous other medications that are also metabolized by, or inhibit/induce, CYP3A4. These interactions can significantly alter the plasma concentrations of Diltiazem or the co-administered drug, potentially leading to increased side effects or reduced efficacy. Close monitoring and dose adjustments are often necessary when Diltiazem is used concurrently with other medications.

• Beta-blockers: Concomitant use with beta-blockers can lead to additive effects on heart rate and AV nodal conduction, increasing the risk of severe bradycardia, heart block, and hypotension.
• Digoxin: Diltiazem can increase plasma concentrations of digoxin, potentially leading to digoxin toxicity. Monitoring of digoxin levels is recommended.
• Statins (e.g., Simvastatin, Lovastatin): Diltiazem inhibits CYP3A4, which can increase the plasma concentrations of certain statins, raising the risk of myopathy and rhabdomyolysis. Lower doses of statins or alternative statins may be necessary.
• Benzodiazepines (e.g., Midazolam, Triazolam): Diltiazem can increase the levels of certain benzodiazepines metabolized by CYP3A4, leading to enhanced sedative effects.
• Grapefruit Juice: Grapefruit juice can inhibit CYP3A4, potentially increasing Diltiazem plasma levels and enhancing its effects. Patients are often advised to avoid grapefruit juice.
• Other Antihypertensives: Concurrent use with other drugs that lower blood pressure (e.g., ACE inhibitors, ARBs, diuretics) can lead to additive hypotensive effects, necessitating careful monitoring of blood pressure.

🚫 Contraindications & Warnings

Diltiazem is a potent cardiovascular medication and is not suitable for all patients. Certain medical conditions or situations contraindicate its use due to the potential for serious adverse effects. It is crucial for patients to disclose their full medical history to their healthcare provider before initiating therapy with Diltiazem.

• Hypersensitivity: Patients with a known allergy or hypersensitivity to Diltiazem or any component of its formulation should not use this medication.
• Sick Sinus Syndrome or Second/Third-Degree AV Block: Unless a functioning ventricular pacemaker is in place, Diltiazem is contraindicated in patients with these severe cardiac conduction disturbances due to the risk of profound bradycardia or asystole.
• Severe Hypotension: Patients with markedly low blood pressure (<90 mmHg systolic) should not be given Diltiazem, as it can further exacerbate hypotension.
• Acute Myocardial Infarction with Pulmonary Congestion: Diltiazem is contraindicated in patients with acute myocardial infarction complicated by pulmonary congestion, as it may worsen cardiac function.
• Ventricular Tachycardia: Intravenous Diltiazem is contraindicated for the treatment of ventricular tachycardia, as it can cause hemodynamic deterioration.
• Pregnancy and Lactation: Diltiazem should be used with caution during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk and generally not recommended for nursing mothers.

Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.

❓ Frequently Asked Questions

Is Diltiazem safe for long-term use?

Yes, Diltiazem is generally considered safe and effective for long-term use in managing chronic conditions like hypertension and angina, provided it is prescribed and monitored by a healthcare professional. Regular follow-up appointments are essential to monitor its efficacy, assess for any side effects, and ensure the dosage remains appropriate. Patients should not stop taking Diltiazem abruptly without consulting their doctor, as this can lead to a rebound increase in blood pressure or angina.

Can Diltiazem be taken with food?

Yes, Diltiazem can typically be taken with or without food. However, taking it with food, particularly with meals, can sometimes help to reduce gastrointestinal upset such as nausea, which is a possible side effect for some individuals. For extended-release formulations, consistency is key; some manufacturers recommend taking it at approximately the same time each day, often with a meal, to ensure optimal absorption and sustained therapeutic effect.

What should I do if I miss a dose of Diltiazem?

If you miss a dose of Diltiazem, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double your dose to make up for a missed one, as this can increase the risk of side effects. If you frequently miss doses or are unsure, consult your doctor or pharmacist for guidance.

Where can I buy Diltiazem?

Diltiazem is a prescription medication, meaning it cannot be purchased over-the-counter. You can obtain Diltiazem only through a valid prescription from a licensed healthcare provider (such as a doctor or specialist). Once you have a prescription, you can purchase it from licensed pharmacies, either brick-and-mortar establishments or reputable online pharmacies that require a prescription. It is crucial to obtain Diltiazem through legitimate medical channels to ensure you receive a safe, effective, and authentic product.